Refine
Has Fulltext
- yes (12)
Is part of the Bibliography
- yes (12)
Document Type
- Journal article (12)
Language
- English (12)
Keywords
- artificial intelligence (4)
- head and neck cancer (4)
- deep learning (3)
- ARONJ (2)
- HNSCC (2)
- cancer metabolism (2)
- classification (2)
- machine learning (2)
- osteonecrosis of the jaw (2)
- osteoradionecrosis (2)
- prediction (2)
- AMPK (1)
- CD44 (1)
- Compound 3k (1)
- DASA-58 (1)
- HGF (1)
- MRONJ (1)
- Met (1)
- OHIP-49 (1)
- ONJ (1)
- PET (1)
- PKM2 (1)
- SWLS (1)
- TXNIP (1)
- Warburg effect (1)
- X-ray (1)
- agar diffusion test (1)
- alveolar bone loss (1)
- ampicillin (1)
- antibiotic bone concentration (1)
- antiresorptive drug-related osteonecrosis of the jaw (1)
- beta-lactam (1)
- cancer (1)
- case report (1)
- complications (1)
- computer-aided (1)
- design (1)
- fibroblast activation protein (1)
- fibula (1)
- glycolysis (1)
- graft (1)
- intraosseous (1)
- ischemia (1)
- jaw bone (1)
- length of stay (1)
- mandible (1)
- mandibular (1)
- manufacturing (CAD/CAM) (1)
- maxillofacial surgery (1)
- medication-related osteonecrosis of the jaw (1)
- molecular imaging (1)
- object detection (1)
- operative planning (1)
- oral health (1)
- oral microbiome (1)
- oral-health-related quality of life (1)
- oro-antral communication (1)
- oro-antral fistula (1)
- oroantral fistula (1)
- osteocutaneous (1)
- planning (1)
- preoperative (1)
- pseudocarcinomatous hyperplasia (1)
- radiographic bone loss (1)
- reconstruction (1)
- satisfaction with life (1)
- teeth extraction (1)
- tooth extraction (1)
- treatment benefit (1)
Institute
- Klinik und Poliklinik für Mund-, Kiefer- und Plastische Gesichtschirurgie (12)
- Comprehensive Cancer Center Mainfranken (2)
- Institut für Hygiene und Mikrobiologie (2)
- Institut für Pharmazie und Lebensmittelchemie (2)
- Pathologisches Institut (2)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (1)
- Klinik und Poliklinik für Hals-, Nasen- und Ohrenkrankheiten, plastische und ästhetische Operationen (1)
- Klinik und Poliklinik für Nuklearmedizin (1)
- Medizinische Klinik und Poliklinik II (1)
- Poliklinik für Zahnärztliche Prothetik (1)
- Theodor-Boveri-Institut für Biowissenschaften (1)
Sonstige beteiligte Institutionen
Purpose
While [\(^{18}\)F]-fluorodeoxyglucose ([\(^{18}\)F]FDG) is the standard for positron emission tomography/computed tomography (PET/CT) imaging of oral squamous cell carcinoma (OSCC), diagnostic specificity is hampered by uptake in inflammatory cells such as neutrophils or macrophages. Recently, molecular imaging probes targeting fibroblast activation protein α (FAP), which is overexpressed in a variety of cancer-associated fibroblasts, have become available and might constitute a feasible alternative to FDG PET/CT.
Methods
Ten consecutive, treatment-naïve patients (8 males, 2 females; mean age, 62 ± 9 years) with biopsy-proven OSCC underwent both whole-body [\(^{18}\)F]FDG and [\(^{68}\)Ga]FAPI-04 (FAP-directed) PET/CT for primary staging prior to tumor resection and cervical lymph node dissection. Detection of the primary tumor, as well as the presence and number of lymph node and distant metastases was analysed. Intensity of tracer accumulation was assessed by means of maximum (SUV\(_{max}\)) and peak (SUV\(_{peak}\) standardized uptake values. Histological work-up including immunohistochemical staining for FAP served as standard of reference.
Results
[\(^{18}\)F]FDG and FAP-directed PET/CT detected all primary tumors with a SUVmax of 25.5 ± 13.2 (FDG) and 20.5 ± 6.4 (FAP-directed) and a SUVpeak of 16.1 ± 10.3 ([\(^{18}\)F]FDG) and 13.8 ± 3.9 (FAP-directed), respectively. Regarding cervical lymph node metastases, FAP-directed PET/CT demonstrated comparable sensitivity (81.3% vs. 87.5%; P = 0.32) and specificity (93.3% vs. 81.3%; P = 0.16) to [\(^{18}\)F]FDG PET/CT. FAP expression on the cell surface of cancer-associated fibroblasts in both primary lesions as well as lymph nodes metastases was confirmed in all samples.
Conclusion
FAP-directed PET/CT in OSCC seems feasible. Future research to investigate its potential to improve patient staging is highly warranted.
Head and neck squamous cell carcinoma (HNSCC) is known to overexpress a variety of receptor tyrosine kinases, such as the HGF receptor Met. Like other malignancies, HNSCC involves a mutual interaction between the tumor cells and surrounding tissues and cells. We hypothesized that activation of HGF/Met signaling in HNSCC influences glucose metabolism and therefore substantially changes the tumor microenvironment. To determine the effect of HGF, we submitted three established HNSCC cell lines to mRNA sequencing. Dynamic changes in glucose metabolism were measured in real time by an extracellular flux analyzer. As expected, the cell lines exhibited different levels of Met and responded differently to HGF stimulation. As confirmed by mRNA sequencing, the level of Met expression was associated with the number of upregulated HGF-dependent genes. Overall, Met stimulation by HGF leads to increased glycolysis, presumably mediated by higher expression of three key enzymes of glycolysis. These effects appear to be stronger in Met\(^{high}\)-expressing HNSCC cells. Collectively, our data support the hypothesized role of HGF/Met signaling in metabolic reprogramming of HNSCC.